Log in to save to my catalogue

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9151693

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

About this item

Full title

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2022-06, Vol.132 (11), p.1-15

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

CD13, an ectoenzyme on myeloid and stromal cells, also circulates as a shed, soluble protein (sCD13) with powerful chemoattractant, angiogenic, and arthritogenic properties, which require engagement of a G protein-coupled receptor (GPCR). Here we identify the GPCR that mediates sCD13 arthritogenic actions as the bradykinin receptor B1 (B1R). Immuno...

Alternative Titles

Full title

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9151693

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9151693

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI151827

How to access this item